On Monday shares of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) closed at $14.84.
Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) announced that it will present a corporate overview at the 14th Annual Needham Healthcare Conference, Tuesday, April 14, 2015 at 4:20 p.m. ET at The Westin Grand Central Hotel in New York City.
Aerohive Networks, Inc. (NYSE:HIVE) in last trading activity decreased -0.59% to close at $5.07. Company weekly performance is 9.27% while its quarterly performance stands at 7.42%. Aerohive Networks, Inc. (NYSE:HIVE) is -56.81% away from its 52 week high. Aerohive Networks, Inc. (NYSE:HIVE) announced preliminary results for the first quarter of fiscal year 2015 ended March 31, 2015 as well as preliminary guidance for the second quarter of fiscal year 2015. Aerohive expects net revenue for the first quarter to be in the range of $25 million to $26 million, which is below the Company’s previously stated guidance of $29 million to $31 million.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) in last trading activity moved up 0.12% to close at $182.90. Company weekly performance is 7.19% while its quarterly performance stands at -0.74%. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is -10.03% away from its 52 week high. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced that the Company will report its financial results for the first quarter ended March 31, 2015 on Thursday, April 23, 2015 before the US financial markets open.
On last trading day Pfizer Inc. (NYSE:PFE) moved down -0.99% to close at $35.09. Its volatility for the week is 1.48% while volatility for the month is 1.55%. PFE’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was 3.10%. Pfizer Inc. (NYSE:PFE) monthly performance is 3.21%. On 9 April, Pfizer Inc. (NYSE:PFE) said that, has extended the terms of its global collaboration with Pfizer Inc. PFE to create Accurins (targeted and programmable therapeutics) that optimize the therapeutic potential of two molecularly targeted oncology drugs in Pfizer’s pipeline.
On last trading day Precision Castparts Corp. (NYSE:PCP) decreased -0.29% to close at $212.39. Its volatility for the week is 1.24% while volatility for the month is 1.53%. PCP’s sales growth for past 5 years was 7.30% and its EPS growth for past 5 years was 10.30%. Precision Castparts Corp. (NYSE:PCP) monthly performance is 1.16%. Precision Castparts Corp. (NYSE:PCP) has received an “A” credit rating from analysts at Morningstar. The investment research firm’s “A” rating indicates that the company is a low default risk. They also gave their stock a three star rating.